Pfizer (PFE) Tops Q4 EPS by 7c; Guides FY 23 Below the Street
Get Alerts PFE Hot Sheet
Price: $25.26 --0%
Revenue Growth %: -23.7%
Financial Fact:
Diluted (in shares): 6.14B
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: -23.7%
Financial Fact:
Diluted (in shares): 6.14B
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $1.14, $0.07 better than the analyst estimate of $1.07. Revenue for the quarter came in at $24.29 billion versus the consensus estimate of $24.61 billion.
GUIDANCE:
Pfizer sees FY2023 EPS of $3.25-$3.45, versus the consensus of $4.44. Pfizer sees FY2023 revenue of $67-71 billion, versus the consensus of $74.13 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- LyondellBasell Industries (LYB) Tops Q1 EPS by 17c
- Barnes Group (B) Tops Q1 EPS by 2c; Raises guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!